Koremen(TB4, KPV,BPC157) 25mg+10mg+10mg (Blend)

▎ Wetin na KPV?

KPV na tripεptida kכmpawnd we kכmכp wit laysin (Lys), prolin (Pro), εn valin (Val). na aktv fragmεnt fכ α-melanosayt-stimulεt כmon (α-MSH) wit difrεnt bayolojikal aktiviti. KPV de du in ifekt dεm tru anti-inflammatory akshכn εn tisu ripa prכmoshכn. i de mכdulet di inflammatory cytokine lεvεl dεm, i de inhεbit di pro-inflammatory mεdiate rilis, εn i de εliviet di lokal inflammatory rεspכns dεm. di sem tεm, i de mek di sεl dεm muv εn proliferashכn, i de aksεlεrat di ripa εn rigεnεreshכn fכ di mכkus כ tisu dεm we dεn dכn pwεl fכ mek fayn envayroment fכ di lεshכn hεl. I kɔr tritmɛnt valyu de fɔ trit inflammatory sik dɛm. fכ כlsεraytiv kolεt, KPV we dεn gi rεktal כ כral (bכku tεm dεn kin εnhans wit nanocarrier כ haydrojεl fכ impruv tכgεt) de ridyus di kכlon inflameshn bכku bכku wan, i de ripεr mכkus dεm we dεn dכn pwεl, i de lכs di sik aktiviti indis, εn i de mek di kכlon mכfכlכji ristכreshכn. insay dεmatכlכji, dεn de εksplכr KPV in anti-inflammatory prכpati dεm εn melanosayt-εnhans ifekt dεm fכ vitiligo tritmεnt. di tכpik dεlivεri sistεm dεm de bכst di melanin sεntesis εn sεl proliferashכn, we de εp fכ ripigmεnt fכ di skin we afekt. apat frכm dat, in tisu ripa prכpati dεm de gi tεrapi pכtεnshal fכ כda mכkus injuri כ inflameshn-rεlatεd kכndishכn dεm.

▎ Wetin na BPC-157?

BPC-157 de du mכlti fכs bayolojikal aktiviti dεm bay we i de rεgεl di εksprεshכn fכ di kכl mכlikul dεm lεk vaskulεr εndoteyl grכw fכktכ, εndoteyl nitric oksayd sεntez, εn gכt hכmon rεsεpכta dεm, we de sho patikyula efikכs fכ tisu ripa εn protεkshכn. i de promuot fibroblast maygrεshכn εn kolagen sεntesis, aksεlεrayt angiojεnεsis, εn de gi dεmεd tisu dεm wit ampli nyutrishכnal sכpכt εn ripa mכmεnt, we de achy sistεmik sεlyul protεktiv ifekt dεm.

insay di gεstrointestinal aplikεshכn, in valyu bכku: i de ripa di gastric mכkus dεm fayn fayn wan, i de kכntrכl כlsa dεm we alkol כ NSAID dεm de mek, i de ridyus di כlsa εria, εn i de mek di כlsa hεl. Fɔ inflammatory bowel diseases lɛk ɔlcerative colitis ɛn Crohn’s disease, i de ridyus di pro-inflammatory factor rilis, i de mek di intestinal inflammation nɔ bɔku, i de mek di ripa kwik kwik wan na di anastomotic sayt dɛm, ɛn i de mek di bowel wok fayn.

insay di mכskul skel sistεm, BPC-157 de aktibכt path dεm we riliyt to tεndon sεl proliferashכn εn maygrεshכn, we de protεkt rigεnεraytiv ripa afta tεndon εn ligament injuri εn sכt di rεkכvεshכn pεriכd afta sכpכt injuri כ כpεrayshכn. I de mek bak di bon difεkt hεl εn di katilej rigεnεreshכn, i de rεdכks di jכyn inflameshn, εn i de impכkt fayn fayn wan pan kכndishכn dεm lεk כstio-arayt.

fכ nyuroprotεkshכn, i de mכdulet di hipokamp jin εksprεshכn insay spεnal kכd injuri mכdel dεm fכ εp mכtal fכnshכn rεkכvεshכn. I de mek di nyuronal damej we di sεribra ischemia kin mek, i de ridyus di nyurol dεfisit dεm afta di strok, εn i de mitigate di simptom dεm na di mכdel dεm fכ di sik we dεn kכl Pakinson εn skizofrenia, we de sho se di nyuroprotεktiv pכtεnshal. BPC-157 de mek pipul dεn hεl pan bכn, traumatik, εn afta dεn dכn כpεrayshכn wund dεm. bay we i de mek di blɔd flɔ fayn fayn wan to di ischemic tisu dɛm, i de gi tritmɛnt bɛnifit fɔ ischemic sik dɛm.

Dɔn

di sinagεstik intarakshכn fכ TB500, KPV, εn BPC-157 insay di Coremend blεnd de establish wan kaskad rεgεdyushכn nεtwכk fכ 'anti-inflammatory - ripa - rijεneshכn' kaskad rεgεlεtכri nεtwכk, we de achy kכmprεhεnsiv bayolojikal ifekt dεm we wan wan kכmכpכnt dεm nכ go ebul fכ atεn. KPV de prayoritayz fכ ridyus di lokal tisu inflameshn bay we i de inhεbit pro-inflammatory fכktכ rilis, we de mek wan lכw-inflammatory maykro envayroment we kכndukt fכ ripa we de afta dat. di prכmoshכn we i de mek fכ di mכkus sεl proliferashכn εn maygrεshכn de initiate di ripa prכsεs na di εria dεm we dεn dכn pwεl. we i de bil pan dis fawndeshכn, TB500 de aksεlεrayt sεl maygrεshכn bay we i de rεgεl aktin dinamiks we i de stimulat angiojεnεsis εn kolagen sεntesis, we de gi di mεtirial bεsis fכ strכkchכral tisu ripa. di initiashכn fכ kכnektiv tisu rigεnεreshכn de fכm wan sikεns sinagεshכn wit KPV in εli stej inflameshn kכntrכl. BPC-157 de εnhans angiojεnεsis efyushכn bay we i de upregulate mכlikul εksprεshכn fכ vaskulεr εndoteyl grכw fכktכ εn εndoteyl nitric oksayd sεntez, we i de bכst fכblast aktiviti. dis de amplify TB500 in angiogenic ifekt dεm fכ mek sכh se nyutriεnt saplai εn i de ridyus sεkכnd dεm we i de ripa tru in saytoprotektiv fכnshכn. i mכlti-tisu ripa kεpabiliti dεm (gastrointestinal trakt, mכskul skel sistεm, nεv sεstem) kכmplimεnt TB500 in kכnektiv tisu rigεnεreshכn εn KPV in mכkus rεpa tru tisu-tכgεt sinagεj. we dεn sinagayz, KPV in anti-inflammatory akshכn de εliminet di ripa barεri dεm, TB500 in rijεneshכn initiashכn de establish strכkchכral fawndeshכn dεm, εn BPC-157 in fכnshכnal εnhansmεnt εn sεl protεkshכn de εlevεt ripa kwaliti εn efyushכn. tכgeda, dεn de aksεlεrayt di כl prכsεs frכm inflameshn rεsכlushכn to strכkchכral rεkכnstrכkshכn εn fכnshכnal rεkכvεshכn insay dεmεj tisu dεm, we de gi wan hεli sinagεstik intavεnshכn mכdel fכ kכmpleks tisu injuri εn inflameshn-rεlatεd sik dεm.

Bɔt di pɔsin we rayt di buk

Di tin dɛn we wi dɔn tɔk bɔt ɔp, na ɔl di tin dɛn we Cocer Peptides dɔn du risach, ɛdit ɛn kɔmpilayt.

ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.  

Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto mɛrɛsin, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.